Jerome Yates became a cancer doctor during a time when medical oncologists were thought to be what he describes as “the garbage collectors of medicine.”
As a community, we strive for cancer treatment and research that is data-driven, patient-centered, and that meets the highest standards of quality and safety. Yet, as physicians and advocates, we’ve become aware of a situation where these ambitions are not being met.
After nearly five years in the federal government—at both NCI and FDA—Ned Sharpless is stepping down from his position as NCI director.
Chemotherapy at Ukraine’s National Cancer Institute in Kyiv no longer has to be administered in underground bomb shelters.
Join the Cancer History Project April 20 at 7 p.m. EST for a panel moderated by Dr. Narjust Duma of Dana-Farber Cancer Institute. Four directors of NCI-designated cancer centers will discuss their unique perspectives as immigrants—and leaders in oncology. Topics will cover their unique pathways to leadership, diversity in medicine, and challenges faced by international medical graduates.
Bernard Fisher revolutionized the understanding of breast cancer—but 28 years ago this week, NCI jettisoned him from his position as chair of the National Surgical Adjuvant Breast and Bowel Project.
Carol Fabian recalls the emotional hardship that came with treating women for breast cancer in the 1970s and eighties.
There is arguably no pair of oncology’s founders more famous than James Holland, longtime chairman of the Acute Leukemia Group B (ALGB), and Jimmie Holland, the founder of psycho-oncology.
After ferrying her son to safety across the Hungarian border, Nataliia Verovkina has returned to Kyiv to resume treating cancer patients.
Most of these medical pioneers, nicknamed the “Cancer Cowboys” are gone now. Their ranks once included James Holland, Tom Frei and Emil “Jay” Freireich. Arguably, the best known of this group, Donald Pinkel, died March 9 at his home in San Luis Obispo, CA, at the age of 95.
